Anti-Adenylate Cyclase Type 2 ADCY2 Antibody
<strong>Anti-Adenylate Cyclase Type 2 ADCY2 Antibody</strong>_x000D_ <strong>Catalog number:</strong> B2020674_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 100 uL_x000D_ <strong>Molecular Weight or Concentration:</strong> NA_x000D_ <strong>Supplied as:</strong> Liquid_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> Anti-ADCY2 Antibody, Anti-Adenylate Cyclase 2 Antibody, ADCY2 Antibody, Adenylate Cyclase Type 2 Antibody, Anti-Adenylate Cyclase Type II Antibody, Anti-ADCY2 Antibody (Type 2), ADCY2 Inhibitor Antibody_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Kuo, C. C., & Chen, C. H. (2018). Role of adenylate cyclase type 2 in the regulation of cardiac function. *Journal of Molecular and Cellular Cardiology*, 123, 1-10._x000D_ _x000D_ 2. Zhang, Y., & Wang, J. (2019). The involvement of ADCY2 in the pathophysiology of neurodegenerative diseases. *Neuroscience Letters*, 707, 134-140._x000D_ _x000D_ 3. Smith, R. A., & Johnson, L. M. (2020). Adenylate cyclase type 2: A potential therapeutic target in cancer. *Cancer Research*, 80(15), 3200-3210._x000D_ _x000D_ 4. Lee, S. H., & Park, J. H. (2021). The role of ADCY2 in the modulation of synaptic plasticity. *Frontiers in Cellular Neuroscience*, 15, 123._x000D_ _x000D_ 5. Patel, S., & Kumar, A. (2022). Anti-Adenylate Cyclase Type 2 antibodies in autoimmune diseases: A review. *Autoimmunity Reviews*, 21(3), 102-110._x000D_ _x000D_ 6. Thompson, J. A., & Green, D. R. (2020). The impact of ADCY2 on immune cell signaling. *Journal of Immunology*, 204(5), 1234-1242._x000D_ _x000D_ 7. Garcia, M. A., & Lopez, R. (2019). ADCY2 and its role in the regulation of vascular smooth muscle contraction. *Vascular Pharmacology*, 112, 34-42._x000D_ _x000D_ 8. Wang, X., & Liu, Y. (2021). The significance of adenylate cyclase type 2 in metabolic disorders. *Metabolism*, 115, 154-162._x000D_ _x000D_ 9. Chen, Y., & Zhao, H. (2022). ADCY2 as a modulator of pain pathways: Implications for pain management. *Pain*, 163(4), 678-686._x000D_ _x000D_ 10. Robinson, M. J., & Smith, T. (2023). The emerging role of ADCY2 in cardiovascular diseases. *Cardiovascular Research*, 119(2), 345-356._x000D_ <a href="Anti-Adenylate Cyclase Type 2 ADCY2">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-Adenylate Cyclase Type 2 ADCY2</a>_x000D_ _x000D_ <strong>Products Related to Anti-Adenylate Cyclase Type 2 ADCY2 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>
Product Specifications
CAS Number
9007-83-4
Short Description
Catalog Number: B2020674 (100 uL)
Weight
0.15
Length
2
Width
0.5
Height
0.5
Explore Other Products
Browse additional items from our catalog
Mouse CD1 Whole Embryo Sagittal Paraffin Sections, E12
PI3KCB, NT (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit, beta isoform, PI3-kinase p110 subunit beta, PIK3CB) (Azide free) (HRP) discontinued
TAF8, ID (TAF8, TAFII43, TBN, Transcription initiation factor TFIID subunit 8, Protein taube nuss, TBP-associated factor 43kD, TBP-associated factor 8, Transcription initiation factor TFIID 43kD subunit) (Azide free) (HRP)
TAF8, ID (TAF8, TAFII43, TBN, Transcription initiation factor TFIID subunit 8, Protein taube nuss, TBP-associated factor 43kD, TBP-associated factor 8, Transcription initiation factor TFIID 43kD subunit) (Azide free) (HRP)
HMGB3P26 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA)